280
Participants
Start Date
July 17, 2019
Primary Completion Date
February 20, 2022
Study Completion Date
December 19, 2022
Icosabutate
Icosabutate oral capsule once daily
Placebo
Matching placebo oral capsule
Hunter Holmes McGuire VA Medical Center, Richmond
Cumberland Research Associates, LLC, Fayetteville
Gastrointestinal Specialists of Georgia PC, Marietta
Excel Medical Clinical Trials, LLC, Boca Raton
Covenant Research LLC, Sarasota
Sensible Healthcare LLC, Ocoee
Central ResearchAssociates Inc., Birmingham
Premier Research, Clarksville
Gastro One, Germantown
Southern Therapy and Advanced Research LLC, Jackson
Gastrointestinal Associates, PA, Flowood
Aventiv Research, Inc., Columbus
University of Chicago, Chicago
Kansas City Research Institute, Kansas City
Tandem Clinical Research, Marrero
Texas Digestive Disease Consultants, Baton Rouge
Arkansas Gastroenterology - North Little Rock, North Little Rock
Texas Digestive Disease Consultants, Dallas
Liver Associates of Texas, Houston
Texas Digestive Disease Consultants - Webster, Webster
Quality Research Inc, San Antonio
American Research Corporation, San Antonio
Pinnacle Clinical Research, San Antonio
Brooke Army Medical Center, San Antonio
Doctors Hospital at Renaissance, LLC, McAllen
South Texas Research Institute, Edinburg
Pinnacle Clinical Research, Austin
South Denver Gastroenterology, Englewood
Arizona Liver Health, Chandler
Arizona Liver Health - Glendale, Glendale
Arizona Liver Health, Tucson
Adobe Clinical Research, LLC, Tucson
National Research Institute - Wilshire, Los Angeles
National Research Institute - Huntington Park, Huntington Park
National Research Institute - Panorama, Panorama City
Alliance Clinical Research, Poway
National Research Institute - Santa Ana, Santa Ana
Fresno Clinical Research Center, Fresno
Fundacion de Investigacion (FDI), San Juan
Lead Sponsor
NorthSea Therapeutics B.V.
INDUSTRY